Immunovirological improvement in partially HAART responder HIV‐infected patients by monocyte adsorption apheresis
暂无分享,去创建一个
A. Lazzarin | M. Clerici | P. Ferrante | A Lazzarin | M Clerici | H Hasson | L Fumagalli | P Ferrante | A R Saniabadi | M Adachi | A Beretta | H. Hasson | A. Saniabadi | A. Beretta | M. Adachi | L. Fumagalli
[1] Amalio Telenti,et al. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART) , 1998, The Lancet.
[2] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[3] R. Kasukawa,et al. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. , 1998, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.
[4] D. Greenberg. At ground zero , 1996, Nature.
[5] J Leibowitch,et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. , 1997, Science.
[6] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[7] J. Mellors,et al. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. , 1991, The Journal of infectious diseases.
[8] A. Fauci,et al. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.